Stocky
LMAT
LeMaitre Vascular, Inc.
NASDAQ NMS - GLOBAL MARKET · Health Care · US
81.30
▲ +2.91%

Stocky turns companies like LeMaitre Vascular, Inc. into a fun, safe way to learn investing — a virtual portfolio, live scores & charts, and real analyst data, with no real money.

Try Stocky free →

What's happening at LeMaitre Vascular, Inc.

LeMaitre Vascular, Inc.'s latest moves, explained simply — so you know why the numbers change.

Straight from SEC filings · updated 6 Aug 2026
Big update 5 Aug 2026

Files second quarter 2026 financial results and statements

Quarterly reports show if the company is making money and growing as expected.

SEC 10-Q · filed 2026-08-05 View filing ↗
Earnings 4 Aug 2026

Announces Q2 2026 earnings results and business updates

Earnings announcements reveal how well the company performed and guide future expectations.

SEC 8-K · filed 2026-08-04 View filing ↗
Governance 5 Jun 2026

Stockholders elect David Roberts and John Roush as directors

Directors oversee company management; knowing who they are matters for company leadership.

SEC 8-K · filed 2026-06-05 View filing ↗
Earnings 6 May 2026

Files first quarter 2026 financial results and statements

Quarterly reports show if the company is making money and growing as expected.

SEC 10-Q · filed 2026-05-06 View filing ↗
Earnings 5 May 2026

Announces Q1 2026 earnings results and business updates

Earnings announcements reveal how well the company performed and guide future expectations.

SEC 8-K · filed 2026-05-05 View filing ↗
Governance 14 Apr 2026

Board reduces size from eight to seven members

Board changes affect how decisions get made and who leads the company.

SEC 8-K · filed 2026-04-14 View filing ↗
Earnings 26 Feb 2026

Files 2025 annual financial results and full-year statements

Annual reports show total yearly earnings and give the complete financial picture.

SEC 10-K · filed 2026-02-26 View filing ↗

Common questions

How does Stocky track LeMaitre Vascular, Inc.'s company events?

Stocky reads LeMaitre Vascular, Inc.'s official filings with the U.S. Securities and Exchange Commission (SEC) — the 8-K, 10-Q and 10-K reports every public company must file — and summarizes each one in plain English, with a link back to the original document.

What was LeMaitre Vascular, Inc.'s most recent SEC filing?

LeMaitre Vascular, Inc.'s most recent tracked filing was a 10-Q on 5 Aug 2026: Files second quarter 2026 financial results and statements.

Is this financial advice?

No. These event summaries are educational — generated from public SEC filings to help beginners understand what a company is doing. They are not buy or sell recommendations.

See LeMaitre Vascular, Inc. the Stocky way

This page is just a preview. Open the live, interactive version for the full picture:

🎯
Stocky Verdict
A plain-English Buy / Hold / Sell score out of 100.
🌱
Compounder & Value scores
How strong the business is — and whether it looks cheap.
📈
Interactive charts
1M to 5Y price history with company events plotted on it.
Top analyst targets
What the best-rated Wall Street analysts expect next.
⏱️
What if? simulator
See what an investment in LMAT would be worth today.
💼
Practice portfolio
Buy LMAT with virtual money and track it — zero risk.
Free · no real money · learn by doing Open LMAT in Stocky →
See LeMaitre Vascular, Inc.'s full breakdown in Stocky →

Educational, not financial advice. Company events summarized from public SEC filings.
Data as of 6 Aug 2026.